BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
Anti-CD22 CAR-T Cell Therapy Targeting B Cell Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Evaluation Study of Fear of Cancer Recurrence: Detection, Measure and Risk Factors in Lymphoma Survivorship
- Status
- COMPLETED
- Phase
- NA
Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas
- Status
- RECRUITING
- Phase
- PHASE2
Pembrolizumab in Relapsed and Refractory Gray-Zone Lymphoma (GZL), Primary Central Nervous System Lymphoma (PCNSL), and Other Extranodal Diffuse Large B-cell Lymphomas
- Status
- COMPLETED
- Phase
- PHASE2
Study of MK-2118 Administered as Intratumoral Injection as Monotherapy and in Combination With Pembrolizumab (MK-3475) or by Subcutaneous Injection in Combination With Pembrolizumab in the Treatment of Adults With Advanced/Metastatic Solid Tumors or Lymphomas (MK-2118-001)
- Status
- TERMINATED
- Phase
- PHASE1
Effectiveness of Lay Navigators in Meeting Cancer Patients' Non-Clinical Needs: A Pilot Study
- Status
- COMPLETED
- Phase
- NA
Pedometer Activity Monitoring After ASCT
- Status
- COMPLETED
- Phase
- PHASE2
A Study of INCB050465 in Relapsed or Refractory Mantle Cell Lymphoma Previously Treated With or Without a Bruton's Tyrosine Kinase (BTK) Inhibitor
- Status
- COMPLETED
- Phase
- PHASE2
The CAROLE (CArdiac Related Oncologic Late Effects) Study
- Status
- COMPLETED
- Phase
- N/A
Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Promoting Resiliency Among Lymphoma Survivors: The 3RP-Lymphoma
- Status
- COMPLETED
- Phase
- NA
GlucoCEST MRI in Oncology
- Status
- COMPLETED
- Phase
- NA
AZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
Safety of Allogeneic Hematopoietic Cell Transplantation (HCT) For Patients With Classical Hodgkin Lymphoma (CHL) Treated With Nivolumab
- Status
- COMPLETED
- Phase
- N/A
A Study of Anti-CD19 CAR-T Cell Immunotherapy for Refractory /Relapsed B Cell Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Study of ACTR707 in Combination With Rituximab in Subjects With Relapsed or Refractory B Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Brentuximab Vedotin and BeEAM High-dose Chemotherapy in Lymphomas
- Status
- SUSPENDED
- Phase
- PHASE1/PHASE2